Answers are grounded in this paper and cite their sources.
We identified novel mechanisms whereby TIM-3 suppresses innate immunity as induced by nucleic acids. Interaction of TIM-3 with HMGB1 inhibits the recruitment of nucleic acids to the endosomal compartment of dendritic cells, impairing the transduction of innate immune signals. Thus, TIM-3 is an effective target for enhancing the immunogenicity of nucleic acids in the context of cancer therapy.
No takes yet. Share an insight, caveat, or question.
Masahisa Jinushi (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: